Haemonetics price target raised to $140 by Barrington
Barrington Research raised its Haemonetics price target to $140 per share from $118, according to Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.